Popular Articles

MSCI Asia Pacific index at 8-week low as stocks nosedive
Asian stocks fell, sending the MSCI Asia Pacific Index to an eight-week low, on speculation a US economic recovery will be delayed and as Japan’s Prime Minister called national elections.

Khattar's car servicing foray to branch into branded spare parts
Carnation, the multi-brand car servicing major, today announced plans to roll out its own brand of auto spare parts by mid-2010. “We’ll be launching our own brand of genuine car spare parts,” said Jagdish Khattar, CMD of Carnation, at the formal launch of nine service outlets today.

News of the day

Petronet LNG June qtr net dips 2% at Rs 103 cr
Liquefied natural gas importer Petronet LNG today said its net profit declined by 2.20 per cent at Rs 103.31 crore for the quarter ended June 30, 2009, over the same period last year.
Business Opportunities

US FDA say GSK vaccine blocks cancer virus

The US Food and Drug Administration says a vaccine from GlaxoSmithKline successfully blocks the virus that causes most cases of cervical cancer. - Rest In Peace - JB Chemicals gets USFDA nod for its anti-allergic tablets - Unichem Labs gets USFDA nod for hypertension tablets - GSK to launch "promecta" in India by 2009-end - Ranbaxy receives final USFDA approval for Glycopyrolate - Biomarker to help detect CAD at early stage In documents posted online, the FDA says Cervarix, Glaxo"s vaccine against human papilloma virus or HPV, blocked the virus almost 93% of the time. Side effects with the vaccine were mild, such as soreness at the injection site. Cervarix already is approved in nearly 100 other countries, but has been delayed in the United States since 2007 because the FDA said it needed additional data. The agency will ask a panel of vaccine experts next week whether Cervarix should be approved for girls and women ages 10 to 25.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):